Imperva Inc. (NYSE:IMPV) SVP Mark E. Kraynak sold 2,967 shares of the firm’s stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $46.15, for a total transaction of $136,927.05. Following the completion of the transaction, the senior vice president now directly owns 2,968 shares in the company, valued at $136,973.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Imperva Inc. (NYSE:IMPV) traded down 0.45% on Wednesday, hitting $45.99. 282,248 shares of the stock were exchanged. Imperva Inc. has a 1-year low of $31.11 and a 1-year high of $77.99. The stock’s market cap is $1.48 billion. The stock’s 50-day moving average is $43.40 and its 200-day moving average is $44.50.
Imperva (NYSE:IMPV) last posted its quarterly earnings data on Thursday, May 5th. The company reported ($0.25) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.27) by $0.02. The firm earned $59.80 million during the quarter, compared to the consensus estimate of $59.65 million. During the same period in the prior year, the company posted ($0.26) earnings per share. The company’s revenue for the quarter was up 33.5% compared to the same quarter last year. Analysts forecast that Imperva Inc. will post ($0.14) earnings per share for the current year.
IMPV has been the topic of a number of recent research reports. Nomura reaffirmed a “buy” rating and issued a $55.00 price objective (down from $60.00) on shares of Imperva in a research note on Friday, July 15th. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Imperva in a research note on Tuesday, July 12th. Macquarie initiated coverage on shares of Imperva in a research note on Friday, July 8th. They issued a “neutral” rating and a $46.00 price objective on the stock. Zacks Investment Research cut shares of Imperva from a “hold” rating to a “sell” rating in a research note on Wednesday, July 6th. Finally, Imperial Capital reiterated an “outperform” rating and issued a $55.00 target price on shares of Imperva in a report on Wednesday, July 13th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Imperva currently has an average rating of “Buy” and an average price target of $57.00.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.
